ACP

Acuta Capital Partners Portfolio holdings

AUM $147M
1-Year Est. Return 491.59%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+491.59%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$206M
AUM Growth
-$145M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
45
New
Increased
Reduced
Closed

Top Buys

1
+$8.48M
2
+$8.06M
3
+$7.78M
4
BTAI icon
BioXcel Therapeutics
BTAI
+$7.08M
5
MRSN
Mersana Therapeutics
MRSN
+$5.78M

Top Sells

1
+$24.4M
2
+$20.1M
3
+$15.8M
4
ARWR icon
Arrowhead Research
ARWR
+$13.4M
5
KPTI icon
Karyopharm Therapeutics
KPTI
+$11.3M

Sector Composition

1 Healthcare 93.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$20.9M 10.15%
2,673,718
+1,048,718
2
$18.1M 8.8%
308,500
-299,000
3
$16.7M 8.07%
170,450
+38,200
4
$12M 5.8%
399,500
-257,000
5
$11.3M 5.47%
280,120
-75,880
6
$11.2M 5.42%
770,000
-287,500
7
$10.7M 5.18%
1,070,000
+260,000
8
$9.89M 4.79%
2,360,000
-3,680,000
9
$9.5M 4.6%
+310,078
10
$7.13M 3.45%
628,500
-289,000
11
$7.12M 3.45%
63,200
+40,700
12
$7.04M 3.41%
+19,688
13
$6.05M 2.93%
+184,613
14
$5.7M 2.76%
78,807
15
$5.61M 2.72%
209,500
+22,000
16
$5.6M 2.71%
+560,000
17
$4.82M 2.34%
+33,100
18
$4.71M 2.28%
256,500
-131,000
19
$4.38M 2.12%
139,464
-58,036
20
$4.03M 1.95%
56,000
21
$3.39M 1.64%
23,500
-14,500
22
$3.33M 1.62%
102,000
-46,000
23
$3.16M 1.53%
109,700
-332,800
24
$3.1M 1.5%
+90,950
25
$2.52M 1.22%
53,000
+28,000
1
2